Breaking News Instant updates and real-time market news.

2020-04-22 04:57:54 SNAP Snap $12.44 / -0.47 (-3.64%) 04:57 04/22/20 04/22 04:57 04/22/20 04:57	Snap price target raised to $18 from $15 at Stifel Stifel analyst John Egbert raised the firm's price target on Snap to $18 from $15 and keeps a Buy rating on the shares. The company's results last night came in better than expected as daily active users comfortably beat Street forecasts while revenue topped recently lowered sell-side estimates, Egbert tells investors in a research note. Although Snap will likely see "depressed levels" of growth in coming quarters as the global advertising market experiences disruption from the COVID-19 pandemic, the company's ad business has been "properly fortified to weather the storm," contends the analyst.
SNAP Snap $12.44 / -0.47 (-3.64%) 04/22/20 Pivotal Research Snap price target raised to $21.50 from $20 at Pivotal Research 04/21/20 Deutsche Bank Snap price target lowered to $16 from $19 at Deutsche Bank 04/20/20 Credit Suisse Snap price target lowered to $20 from $25 at Credit Suisse 04/20/20 Credit Suisse Snap price target lowered to $20 from $25 at Credit Suisse

2020-04-22 04:57:54

SNAP

Snap

$12.44 / -0.47 (-3.64%)

04:57

04/22/20

04/22

04:57

04/22/20

04:57

Snap price target raised to $18 from $15 at Stifel

Stifel analyst John Egbert raised the firm's price target on Snap to $18 from $15 and keeps a Buy rating on the shares. The company's results last night came in better than expected as daily active users comfortably beat Street forecasts while revenue topped recently lowered sell-side estimates, Egbert tells investors in a research note. Although Snap will likely see "depressed levels" of growth in coming quarters as the global advertising market experiences disruption from the COVID-19 pandemic, the company's ad business has been "properly fortified to weather the storm," contends the analyst.

SNAP Snap

$12.44 / -0.47 (-3.64%)

04/22/20 Pivotal Research: Snap price target raised to $21.50 from $20 at Pivotal Research

04/21/20 Deutsche Bank: Snap price target lowered to $16 from $19 at Deutsche Bank

04/20/20 Credit Suisse: Snap price target lowered to $20 from $25 at Credit Suisse

04/20/20 Credit Suisse: Snap price target lowered to $20 from $25 at Credit Suisse

TODAY'S FREE FLY STORIES

Earnings	EOG Resources reports Q4 adjusted EPS 71c, consensus 35c » 17:15 02/25/21 02/25 17:15 02/25/21 17:15 EOG EOG Resources $70.60 / -1.79 (-2.47%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EOG EOG Resources $70.60 / -1.79 (-2.47%) 01/04/21 EOG Resources names Ezra Yacob as President 11/05/20 EOG Resources provides three-year capital allocation outlook EOG EOG Resources $70.60 / -1.79 (-2.47%) 02/02/21 Barclays EOG Resources price target lowered to $60 from $67 at Barclays 01/22/21 Piper Sandler EOG Resources price target raised to $70 from $60 at Piper Sandler 01/14/21 Barclays EOG Resources downgraded to Equal Weight from Overweight at Barclays 01/11/21 Mizuho EOG Resources price target raised to $88 from $71 at Mizuho EOG EOG Resources $70.60 / -1.79 (-2.47%) 11/05/20 EOG Resources reports Q3 adjusted EPS 43c, consensus 19c EOG EOG Resources $70.60 / -1.79 (-2.47%) 02/17/21 Texas prohibits natgas firms from taking fuel out of state, Bloomberg says 10/27/20 President Trump weighing executive order to show support for fracking, WSJ says 10/16/20 Betaville says major oil company speculated to consider EOG bid, Bloomberg says EOG EOG Resources $70.60 / -1.79 (-2.47%) 10/31/20 Week in review: How Trump's policies moved stocks 02/26/21 EOG Resources - EOG EOG EOG Resources $70.60 / -1.79 (-2.47%) 01/27/21 EOG Resources put volume heavy and directionally bearish 12/14/20 EOG Resources put volume heavy and directionally bearish 12/07/20 EOG Resources put volume heavy and directionally bearish 10/26/20 EOG Resources call volume above normal and directionally bullish
Syndicate	Edesa Biotech announces $3.5M bought deal offering of common shares » 17:14 02/25/21 02/25 17:14 02/25/21 17:14 EDSA Edesa Biotech $6.60 / +0.2 (+3.13%) Edesa Biotech announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research EDSA Edesa Biotech $6.60 / +0.2 (+3.13%) 01/26/21 Edesa Biotech receives FDA, Health Canada approval for EB05 sub-study 01/11/21 Edesa Biotech expands COVID-19 clinical study to Colombia 11/03/20 Edesa Biotech completes enrollment of over 50% of patients for EB01 cream cohort 10/19/20 Edesa Biotech receives FDA clearance to begin EB05 study in COVID-19 patients EDSA Edesa Biotech $6.60 / +0.2 (+3.13%) 03/30/20 Brookline Edesa Biotech initiated with a Buy at Brookline
Earnings	Vicor reports Q4 EPS 25c, consensus 17c » 17:13 02/25/21 02/25 17:13 02/25/21 17:13 VICR Vicor $90.00 / -5.23 (-5.49%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events VICR Vicor $90.00 / -5.23 (-5.49%) 09/15/20 Vicor announces global distribution agreement with Arrow Electronics VICR Vicor $90.00 / -5.23 (-5.49%) 12/30/20 Needham Needham names Applied Materials top pick in 2021, boosts price target to $110 10/23/20 Needham Vicor price target raised to $95 from $85 at Needham 09/18/20 Northland Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland 07/24/20 BWS Financial Vicor price target raised to $100 from $84 at BWS Financial VICR Vicor $90.00 / -5.23 (-5.49%) 10/22/20 Vicor reports Q3 EPS 13c, consensus 8c 11 Jun 17:00 Today Vicor - VICR
Earnings	Mirati Therapeutics reports Q4 EPS ($2.08), consensus (2.23) » 17:13 02/25/21 02/25 17:13 02/25/21 17:13 MRTX Mirati Therapeutics $195.44 / -6.96 (-3.44%) Reports Q4 revenue $1.7M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events MRTX Mirati Therapeutics $195.44 / -6.96 (-3.44%) 02/10/21 Mirati Therapeutics, MD Anderson announce KRAS research agreement 10/25/20 Mirati reports preliminary results from mutant KRAS selective inhibitor programs 09/18/20 Mirati Therapeutics presents Phase 2 sitravatinib/nivolumab data at ESMO 09/17/20 Mirati Therapeutics, Boehringer collaborate on BI 1701963/MRTX849 combination MRTX Mirati Therapeutics $195.44 / -6.96 (-3.44%) 01/15/21 H.C. Wainwright Mirati Therapeutics price target lowered to $257 from $265 at H.C. Wainwright 12/08/20 JMP Securities Mirati Therapeutics initiated with a Market Perform at JMP Securities 11/17/20 BofA Mirati Therapeutics downgraded to Underperform from Neutral at BofA 11/10/20 Guggenheim Mirati Therapeutics downgraded to Neutral from Buy at Guggenheim MRTX Mirati Therapeutics $195.44 / -6.96 (-3.44%) 11/04/20 Mirati Therapeutics reports Q3 EPS ($1.96), consensus ($1.97) 28 Oct MRTX Mirati Therapeutics $195.44 / -6.96 (-3.44%) 10/26/20 Fly Intel: After-Hours Movers 10/26/20 Fly Intel: Wall Street's top stories for Monday 10/26/20 Fly Intel: Wall Street's top stories at midday 03/01/21 41st Annual Healthcare Virtual Conference
Syndicate	AvalonBay files automatic mixed securities shelf 17:12 02/25/21 02/25 17:12 02/25/21 17:12 AVB AvalonBay $180.39 / -4.67 (-2.52%) ShowHide Related Items >><< Company News Street Research Earnings AVB AvalonBay $180.39 / -4.67 (-2.52%) 12/10/20 AvalonBay names Benjamin Schall president AVB AvalonBay $180.39 / -4.67 (-2.52%) 02/22/21 KeyBanc AvalonBay upgraded to Overweight at KeyBanc on coastal recovery 02/21/21 KeyBanc AvalonBay upgraded to Overweight from Sector Weight at KeyBanc 02/09/21 BofA Camden Property downgraded to Neutral from Buy at BofA 12/21/20 JPMorgan JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021 AVB AvalonBay $180.39 / -4.67 (-2.52%) 02/03/21 AvalonBay Communities sees Q1 core FFO $1.85-$1.95 02/03/21 AvalonBay Communities reports Q4 core FFO $2.43, consensus $2.09 10/28/20 AvalonBay reports Q3 EPS $1.05, consensus 95c

Conference/Events	Viatris to host virtual investor day » 17:11 02/25/21 02/25 17:11 02/25/21 17:11 VTRS Viatris $15.05 / -0.245 (-1.60%) Virtual Investor Day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options VTRS Viatris $15.05 / -0.245 (-1.60%) 02/22/21 Viatris to initiate 11c per share quarterly dividend in May 01/28/21 FTC approves final order on Pfizer, Mylan deal with conditions 12/21/20 Mapi Pharma provides enrollment update on Phase III GA Depot trial 12/18/20 Viatris acquires 27,736 common shares VTRS Viatris $15.05 / -0.245 (-1.60%) 02/23/21 Barclays Viatris price target lowered to $20 from $26 at Barclays 01/06/21 RBC Capital Viatris named one of top stocks to own in 2021 by RBC Capital 01/05/21 Argus Viatris initiated with a Hold at Argus 12/14/20 Bernstein Viatris initiated with a Market Perform at Bernstein VTRS Viatris $15.05 / -0.245 (-1.60%) 02/22/21 Viatris sees FY21 revenue $17.2B-$17.8B, consensus $18.46B 03/01/21 Viatris Inc VTRS Viatris $15.05 / -0.245 (-1.60%) 02/19/21 Viatris call volume above normal and directionally bullish 02/08/21 Viatris put volume heavy and directionally bearish 01/14/21 Viatris call volume above normal and directionally bullish 12/31/20 Viatris call volume above normal and directionally bullish
Hot Stocks	Beyond Meat says 'not prepared to elaborate' on new partnerships » 17:11 02/25/21 02/25 17:11 02/25/21 17:11 BYND Beyond Meat $143.89 / -8.21 (-5.40%) Says plans to hold… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BYND Beyond Meat $143.89 / -8.21 (-5.40%) 16:16 Today Beyond Meat partners with Yum! Brands on plant-based protein menu items 16:14 Today Beyond Meat signs three-year agreement to be McPlant supplier for McDonald's 16:13 Today Beyond Meat not providing FY21 guidance until further notice 02/09/21 Beyond Meat director sells 40K shares of common stock BYND Beyond Meat $143.89 / -8.21 (-5.40%) 02/03/21 Fly Intel: Top five analyst downgrades 02/03/21 DA Davidson Beyond Meat downgraded to Underperform from Neutral at DA Davidson 02/03/21 DA Davidson Beyond Meat downgraded to Underperform from Neutral at DA Davidson 01/27/21 Canaccord Beyond Meat price target raised to $170 from $125 at Canaccord BYND Beyond Meat $143.89 / -8.21 (-5.40%) 16:12 Today Beyond Meat reports Q4 adjusted EPS (34c), consensus (13c) 13:52 Today Notable companies reporting after market close 11/09/20 Beyond Meat reports Q3 adj. EPS (28c), consensus 5c 11/09/20 Notable companies reporting after market close BYND Beyond Meat $143.89 / -8.21 (-5.40%) 02/04/21 Lawsuit challenging FDA approval of Impossible color additive, FSN reports 02/01/21 McDonald's begins introduction of McPlant Burger in test markets, Bloomberg says 11/09/20 Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant' 11/09/20 Beyond Meat says co-created 'McPlant' burger with McDonald's, Reuters reports BYND Beyond Meat $143.89 / -8.21 (-5.40%) 11:47 Today Fly Intel: What to watch in Beyond Meat earnings report 02/03/21 Beyond Meat downgrade, Comcast upgrade among today's top calls on Wall Street 01/27/21 Fly Intel: What to watch in McDonald's earnings report 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 17:00 Today Beyond Meat - BYND BYND Beyond Meat $143.89 / -8.21 (-5.40%) 01/25/21 Beyond Meat call volume above normal and directionally bullish 01/22/21 Beyond Meat call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names 11/18/20 Unusually active option classes on open November 18th
Earnings	AnaptysBio reports Q4 EPS $1.20, consensus $1.39 » 17:11 02/25/21 02/25 17:11 02/25/21 17:11 ANAB AnaptysBio $26.00 / -0.39 (-1.48%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ANAB AnaptysBio $26.00 / -0.39 (-1.48%) 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' 10/26/20 AnaptysBio, GlaxoSmithKline amend strategic immuno-oncology collaboration 10/13/20 AnaptysBio reports topline data from GALLOP Phase 2 trial of imsidolimab ANAB AnaptysBio $26.00 / -0.39 (-1.48%) 02/11/21 JPMorgan JPMorgan double upgrades AnaptysBio, more than doubles price target 02/11/21 JPMorgan AnaptysBio upgraded to Overweight from Underweight at JPMorgan 10/27/20 Fly Intel: Top five analyst upgrades 10/27/20 Truist AnaptysBio price target raised to $27 from $20 at Truist ANAB AnaptysBio $26.00 / -0.39 (-1.48%) 11/04/20 AnaptysBio reports Q3 EPS (87c), consensus (72c) ANAB AnaptysBio $26.00 / -0.39 (-1.48%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street
Earnings	Erie Indemnity reports Q4 EPS $1.20 , consensus $1.21 » 17:11 02/25/21 02/25 17:11 02/25/21 17:11 ERIE Erie Indemnity $243.85 / -4.15 (-1.67%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Events ERIE Erie Indemnity $243.85 / -4.15 (-1.67%) 12/08/20 Erie Indemnity approves management fee rate, raises dividend 09/01/20 Erie appoints Jamie Neumaier as Chief Information Security Officer ERIE Erie Indemnity $243.85 / -4.15 (-1.67%) 10/29/20 Erie Indemnity reports Q3 EPS $1.71, consensus $1.50 02/26/21 Erie Indemnity - ERIE
Earnings	Nektar reports Q4 EPS (65c), consensus (68c) » 17:09 02/25/21 02/25 17:09 02/25/21 17:09 NKTR Nektar $22.47 / -0.29 (-1.27%) Reports Q4 revenue $23.5… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NKTR Nektar $22.47 / -0.29 (-1.27%) 02/17/21 Nektar announces collaboration with SFJ Pharmaceuticals 02/17/21 Nektar enters trial collaboration, supply agreement with Merck 01/05/21 Nektar names Brian Kotzin interim chief medical officer 12/22/20 Nektar sells royalties on future sales of ADYNOVATE and MOVANTIK NKTR Nektar $22.47 / -0.29 (-1.27%) 02/22/21 Benchmark Nektar downgraded to Hold on valuation at Benchmark 02/22/21 Benchmark Nektar downgraded to Hold from Buy at Benchmark 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 02/17/21 Piper Sandler Nektar collaborations could create $500M-$800M opportunity, says Piper Sandler NKTR Nektar $22.47 / -0.29 (-1.27%) 11/05/20 Nektar reports Q3 EPS (61c), consensus (74c) 03/01/21 41st Annual Healthcare Virtual Conference 17:00 Today Nektar - NKTR

Earnings	Codexis sees FY21 revenue $82M-$85M, consensus $80.53M » 17:08 02/25/21 02/25 17:08 02/25/21 17:08 CDXS Codexis $21.23 / -1.67 (-7.29%) Sees FY21 adjusted gross… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CDXS Codexis $21.23 / -1.67 (-7.29%) 01/13/21 Codexis, Tate & Lyle expand relationship to enhance stevia, allulose production CDXS Codexis $21.23 / -1.67 (-7.29%) 12/30/20 Benchmark Codexis price target raised to $29 from $21 at Benchmark 07/15/20 Stephens Codexis resumed with an Overweight at Stephens 03/10/20 Benchmark Codexis initiated with a Buy at Benchmark CDXS Codexis $21.23 / -1.67 (-7.29%) 17:06 Today Codexis reports Q4 EPS (6c), consensus (12c) 11/05/20 Codexis reports Q3 EPS (10c), consensus (11c) 03 Dec CDXS Codexis $21.23 / -1.67 (-7.29%) 12/03/20 Fly Intel: Wall Street's top stories for Thursday 12/03/20 Fly Intel: Wall Street's top stories at midday 12/03/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Codexis - CDXS
Earnings	Assembly Biosciences reports Q4 EPS ($1.75), consensus (90c) » 17:08 02/25/21 02/25 17:08 02/25/21 17:08 ASMB Assembly Biosciences $5.53 / -0.13 (-2.30%) "Our strategy for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ASMB Assembly Biosciences $5.53 / -0.13 (-2.30%) 12/08/20 Assembly Biosciences to wind-down microbiome program 11/17/20 Assembly Biosciences appoints SVP, pharmaceutical development and manufacturing 11/16/20 Assembly Biosciences, Door Pharmaceuticals sign collaboration agreement 11/13/20 Assembly Biosciences presents data from HBV core inhibitor programs ASMB Assembly Biosciences $5.53 / -0.13 (-2.30%) 12/04/20 Mizuho Assembly Biosciences price target lowered to $13 from $30 at Mizuho 11/06/20 Jefferies Assembly Biosciences downgraded to Hold from Buy at Jefferies 10/19/20 Truist Assembly Biosciences initiated with a Buy at Truist 07/21/20 Baird Assembly Biosciences HBV deal a positive, says Baird ASMB Assembly Biosciences $5.53 / -0.13 (-2.30%) 11/05/20 Assembly Biosciences reports Q3 EPS (9c), consensus (75c) ASMB Assembly Biosciences $5.53 / -0.13 (-2.30%) 11/05/20 Fly Intel: After-Hours Movers
Earnings	Pembina Pipeline reports Q4 EPS ($2.28), may not compare to consensus 44c » 17:08 02/25/21 02/25 17:08 02/25/21 17:08 PBA Pembina Pipeline $27.50 / -0.645 (-2.29%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events PBA Pembina Pipeline $27.50 / -0.645 (-2.29%) 01/19/21 Pembina Pipeline announces binding open season 12/14/20 Pembina Pipeline sees FY21 CapEx $730M 12/14/20 Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B PBA Pembina Pipeline $27.50 / -0.645 (-2.29%) 02/09/21 Scotiabank Pembina Pipeline downgraded to Sector Perform from Outperform at Scotiabank 01/27/21 Credit Suisse Pembina Pipeline price target raised to C$42 from C$40 at Credit Suisse 01/27/21 National Bank Pembina Pipeline price target raised to C$38 from C$36 at National Bank 01/22/21 Stifel Pembina Pipeline price target raised to C$37 from C$34 at Stifel 02/26/21 Pembina Pipeline - PBA
Earnings	Ranger Energy reports Q4 EPS (43c), consensus (31c) » 17:06 02/25/21 02/25 17:06 02/25/21 17:06 RNGR Ranger Energy $5.54 / +0.09 (+1.65%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events RNGR Ranger Energy $5.54 / +0.09 (+1.65%) 01/04/21 Evercore ISI Ranger Energy upgraded to Outperform from In Line at Evercore ISI 12/10/20 B. Riley Securities Ranger Energy upgraded to Buy on valuation at B. Riley Securities 12/10/20 B. Riley Securities Ranger Energy upgraded to Buy from Neutral at B. Riley Securities 04/15/20 Piper Sandler Ranger Energy downgraded to Neutral from Overweight at Piper Sandler RNGR Ranger Energy $5.54 / +0.09 (+1.65%) 10/22/20 Ranger Energy reports Q3 EPS (38c), consensus (45c) 03/01/21 26th Annual Energy Virtual Summit 02/26/21 Ranger Energy - RNGR
Earnings	Fly Leasing reports Q4 adjusted EPS ($3.78), consensus (15c) » 17:06 02/25/21 02/25 17:06 02/25/21 17:06 FLY Fly Leasing $12.42 / -0.19 (-1.51%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events FLY Fly Leasing $12.42 / -0.19 (-1.51%) 12/23/20 Fly Leasing rises 22.8% 09/28/20 Fly Leasing rises 19.2% FLY Fly Leasing $12.42 / -0.19 (-1.51%) 01/26/21 Cowen Fly Leasing price target raised to $13 from $9 at Cowen 01/25/21 Deutsche Bank Fly Leasing price target raised to $11 from $8.50 at Deutsche Bank 11/16/20 Deutsche Bank Fly Leasing price target lowered to $8.50 from $10 at Deutsche Bank 05/26/20 JPMorgan JPMorgan upgrades Fly Leasing with stock rally lagging peers FLY Fly Leasing $12.42 / -0.19 (-1.51%) 11/12/20 Fly Leasing reports Q3 adjusted EPS (30c), consensus 36c FLY Fly Leasing $12.42 / -0.19 (-1.51%) 12/23/20 Fly Leasing rallies after Airfinance Journal says considering sale 16:30 Today Fly Leasing - FLY

Earnings	Codexis reports Q4 EPS (6c), consensus (12c) » 17:06 02/25/21 02/25 17:06 02/25/21 17:06 CDXS Codexis $21.23 / -1.67 (-7.29%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CDXS Codexis $21.23 / -1.67 (-7.29%) 01/13/21 Codexis, Tate & Lyle expand relationship to enhance stevia, allulose production CDXS Codexis $21.23 / -1.67 (-7.29%) 12/30/20 Benchmark Codexis price target raised to $29 from $21 at Benchmark 07/15/20 Stephens Codexis resumed with an Overweight at Stephens 03/10/20 Benchmark Codexis initiated with a Buy at Benchmark CDXS Codexis $21.23 / -1.67 (-7.29%) 11/05/20 Codexis reports Q3 EPS (10c), consensus (11c) 03 Dec CDXS Codexis $21.23 / -1.67 (-7.29%) 12/03/20 Fly Intel: Wall Street's top stories for Thursday 12/03/20 Fly Intel: Wall Street's top stories at midday 12/03/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 16:30 Today Codexis - CDXS
Hot Stocks	Southwest Gas sees FY21 CapEx approximately $700M 17:05 02/25/21 02/25 17:05 02/25/21 17:05 SWX Southwest Gas $64.17 / -0.955 (-1.47%) ShowHide Related Items >><< Company News Street Research Earnings Events SWX Southwest Gas $64.17 / -0.955 (-1.47%) 02/24/21 Southwest Gas increases quarterly dividend 4.4% to 59.5c per share SWX Southwest Gas $64.17 / -0.955 (-1.47%) 01/29/21 Fly Intel: Top five analyst downgrades 01/29/21 JPMorgan Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan 01/29/21 JPMorgan Southwest Gas downgraded to Neutral from Overweight at JPMorgan 12/10/20 BofA Southwest Gas cut to Underperform at BofA after AZ rate case decision SWX Southwest Gas $64.17 / -0.955 (-1.47%) 17:05 Today Southwest Gas sees FY21 EPS $3.95-$4.20, consensus $4.18 17:04 Today Southwest Gas reports Q4 EPS $1.82, consensus $1.61 11/05/20 Southwest Gas backs FY20 EPS view $3.75-$4.00, consensus $3.88 11/05/20 Southwest Gas reports Q3 EPS 32c, consensus 24c 02/26/21 Southwest Gas - SWX
Earnings	Southwest Gas sees FY21 EPS $3.95-$4.20, consensus $4.18 17:05 02/25/21 02/25 17:05 02/25/21 17:05 SWX Southwest Gas $64.17 / -0.955 (-1.47%) ShowHide Related Items >><< Company News Street Research Earnings Events SWX Southwest Gas $64.17 / -0.955 (-1.47%) 02/24/21 Southwest Gas increases quarterly dividend 4.4% to 59.5c per share SWX Southwest Gas $64.17 / -0.955 (-1.47%) 01/29/21 Fly Intel: Top five analyst downgrades 01/29/21 JPMorgan Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan 01/29/21 JPMorgan Southwest Gas downgraded to Neutral from Overweight at JPMorgan 12/10/20 BofA Southwest Gas cut to Underperform at BofA after AZ rate case decision SWX Southwest Gas $64.17 / -0.955 (-1.47%) 17:04 Today Southwest Gas reports Q4 EPS $1.82, consensus $1.61 11/05/20 Southwest Gas backs FY20 EPS view $3.75-$4.00, consensus $3.88 11/05/20 Southwest Gas reports Q3 EPS 32c, consensus 24c 02/26/21 Southwest Gas - SWX
Earnings	Southwest Gas reports Q4 EPS $1.82, consensus $1.61 » 17:04 02/25/21 02/25 17:04 02/25/21 17:04 SWX Southwest Gas $64.17 / -0.955 (-1.47%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SWX Southwest Gas $64.17 / -0.955 (-1.47%) 02/24/21 Southwest Gas increases quarterly dividend 4.4% to 59.5c per share SWX Southwest Gas $64.17 / -0.955 (-1.47%) 01/29/21 Fly Intel: Top five analyst downgrades 01/29/21 JPMorgan Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan 01/29/21 JPMorgan Southwest Gas downgraded to Neutral from Overweight at JPMorgan 12/10/20 BofA Southwest Gas cut to Underperform at BofA after AZ rate case decision SWX Southwest Gas $64.17 / -0.955 (-1.47%) 11/05/20 Southwest Gas backs FY20 EPS view $3.75-$4.00, consensus $3.88 11/05/20 Southwest Gas reports Q3 EPS 32c, consensus 24c 02/26/21 Southwest Gas - SWX
Earnings	PetIQ reports Q4 EPS (41c), consensus (10c) » 17:04 02/25/21 02/25 17:04 02/25/21 17:04 PETQ PetIQ $37.25 / +1.77 (+4.99%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options PETQ PetIQ $37.25 / +1.77 (+4.99%) 11/05/20 PetIQ re-opened ~95% of community clinics, wellness centers as of September 30 09/08/20 PetIQ provides reopening update PETQ PetIQ $37.25 / +1.77 (+4.99%) 10/15/20 Jefferies PetIQ assumed with a Buy at Jefferies 08/17/20 Guggenheim Zoetis price target raised to $175 from $139 at Guggenheim 07/01/20 Raymond James PetIQ price target raised to $41 from $35 at Raymond James 06/25/20 Guggenheim PetIQ price target raised to $44 from $33.50 at Guggenheim PETQ PetIQ $37.25 / +1.77 (+4.99%) 11/05/20 PetIQ says FY20 guidance remains suspended due to COVID-19 11/05/20 PetIQ reports Q3 EPS ($2.53), may not compare to consensus 16c 16:30 Today PetIQ - PETQ 03/09/21 PetIQ PETQ PetIQ $37.25 / +1.77 (+4.99%) 11/30/20 Largest borrow rate increases among liquid names

Hot Stocks	Sallie Mae increases price range, extends expiration to buy up to $1B in stock » 17:04 02/25/21 02/25 17:04 02/25/21 17:04 SLM Sallie Mae $14.99 / -0.23 (-1.51%) Sallie Mae announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SLM Sallie Mae $14.99 / -0.23 (-1.51%) 01/26/21 Sallie Mae names Kerri Palmer Chief Risk and Compliance Officer SLM Sallie Mae $14.99 / -0.23 (-1.51%) 01/29/21 Barclays Sallie Mae price target raised to $18 from $15 at Barclays 01/29/21 RBC Capital Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital 01/29/21 Citi Sallie Mae price target raised to $16 from $12 at Citi 01/29/21 RBC Capital Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital SLM Sallie Mae $14.99 / -0.23 (-1.51%) 01/27/21 Sallie Mae reports Q4 core EPS $1.15, consensus 35c 01/27/21 Notable companies reporting after market close 10/21/20 Sallie Mae reports Q3 core EPS 47c, consensus 8c 10/21/20 Notable companies reporting after market close SLM Sallie Mae $14.99 / -0.23 (-1.51%) 02/22/21 Fly Insider: Corvus, ALJ Regional Holdings among week's notable insider trades 01/27/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers SLM Sallie Mae $14.99 / -0.23 (-1.51%) 01/27/21 Sallie Mae put volume heavy and directionally bearish 12/14/20 Unusual call flow in option market yesterday
Earnings	Cardiff Oncology reports Q4 EPS (19c), consensus (14c) » 17:04 02/25/21 02/25 17:04 02/25/21 17:04 CRDF Cardiff Oncology $9.78 / -0.52 (-5.05%) Reports Q4 revenue $119K,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CRDF Cardiff Oncology $9.78 / -0.52 (-5.05%) 02/11/21 Cardiff Oncology announces updated data from Phase 2 mCRPC trial 02/11/21 Cardiff Oncology's onvansertib on track to meet Phase 2 efficacy endpoint 01/26/21 Cardiff Oncology receives 'Study May Proceed' letter from FDA 01/15/21 Cardiff Oncology presents data from Phase 1b/2 study in KRAS-mCRC CRDF Cardiff Oncology $9.78 / -0.52 (-5.05%) 02/11/21 Piper Sandler Piper says Cardiff Oncology mCRPC opportunity 'more interesting' after data 10/22/20 Fly Intel: Top five analyst initiations 10/22/20 H.C. Wainwright Cardiff Oncology initiated with a Buy at H.C. Wainwright 10/21/20 Maxim Cardiff Oncology price target raised to $20 from $14 at Maxim CRDF Cardiff Oncology $9.78 / -0.52 (-5.05%) 11/05/20 Cardiff Oncology reports Q3 EPS (19c), consensus (19c) 30 Sep CRDF Cardiff Oncology $9.78 / -0.52 (-5.05%) 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Fly Intel: Wall Street's top stories at midday 09/29/20 Fly Intel: After-Hours Movers 03/01/21 41st Annual Healthcare Virtual Conference CRDF Cardiff Oncology $9.78 / -0.52 (-5.05%) 09/24/20 Largest borrow rate increases among liquid names
Hot Stocks	Vivint Smart Home sues ADT for patent infringement » 17:04 02/25/21 02/25 17:04 02/25/21 17:04 VVNT Vivint Smart Home $17.37 / -2.02 (-10.42%) , ADT ADT Inc. $9.48 / -0.77 (-7.51%) Vivint Smart Home (VVNT)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options VVNT ADT VVNT Vivint Smart Home $17.37 / -2.02 (-10.42%) 01/06/21 Vivint Smart Home pays $3.2M resolve FIRREA allegations 09/09/20 Vivint Smart Home rises 12.2% ADT ADT Inc. $9.48 / -0.77 (-7.51%) 02/23/21 ADT Inc., Dish partner to bring smart home security to more customers 02/18/21 ADT Inc., Hippo enter partnership for home insurance customers 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 02/10/21 Ackerman Security Systems joins ADT Authorized Dealer Program VVNT ADT VVNT Vivint Smart Home $17.37 / -2.02 (-10.42%) 07:11 Today Deutsche Bank Vivint Smart Home price target lowered to $21 from $24 at Deutsche Bank 01/15/21 Deutsche Bank Vivint Smart Home downgraded to Hold on valuation at Deutsche Bank 01/15/21 Deutsche Bank Vivint Smart Home downgraded to Hold from Buy at Deutsche Bank 11/05/20 JPMorgan Vivint Smart Home price target raised to $34 from $30 at JPMorgan ADT ADT Inc. $9.48 / -0.77 (-7.51%) 01/29/21 Citi ADT Inc. downgraded to Neutral from Buy at Citi 01/29/21 Citi ADT Inc. downgraded to Neutral from Buy at Citi 01/15/21 Deutsche Bank ADT Inc. assumed with a Hold at Deutsche Bank 11/06/20 Roth Capital Alarm.com price target raised to $75 from $65 at Roth Capital VVNT ADT VVNT Vivint Smart Home $17.37 / -2.02 (-10.42%) 02/24/21 Vivint Smart Home sees FY21 revenue $1.38B-$1.42B, consensus $1.39B 02/24/21 Vivint Smart Home reports Q4 revenue $332.5M, consensus $327.12M 11/04/20 Vivint Smart Home backs FY20 revenue view $1.23B-$1.28B, consensus $1.26B 11/04/20 Vivint Smart Home reports Q3 revenue $319M, consensus $316.82M ADT ADT Inc. $9.48 / -0.77 (-7.51%) 16:29 Today ADT Inc. sees FY21 revenue $5.05B-$5.25B, consensus $5.32B 16:26 Today ADT Inc. reports Q4 ex-items EPS (36c), consensus 31c 01/19/21 ADT Inc. reaffirms 2020 revenue view $5.2B-$5.35B, consensus $5.28B 11/05/20 ADT Inc. sees FY20 revenue $5.25B-$5.35B, consensus $5.23B 16 Sep ADT ADT ADT Inc. $9.48 / -0.77 (-7.51%) 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 09/16/20 Fly Intel: Wall Street's top stories for Wednesday 09/16/20 Fly Intel: Wall Street's top stories at midday 09/16/20 Fly Intel: Pre-market Movers 17:00 Today ADT Inc. - ADT VVNT ADT VVNT Vivint Smart Home $17.37 / -2.02 (-10.42%) 09/04/20 Largest borrow rate increases among liquid names 09/03/20 Largest borrow rate increases among liquid names 09/02/20 Largest borrow rate increases among liquid names ADT ADT Inc. $9.48 / -0.77 (-7.51%) 14:35 Today ADT put volume heavy and directionally bearish 01/08/21 ADT call volume above normal and directionally bullish 12/28/20 Unusually active option classes on open December 28th 12/10/20 Unusually active option classes on open December 10th
Earnings	Acadia sees FY21 EPS $2.20-$2.45, consensus $2.56 » 17:02 02/25/21 02/25 17:02 02/25/21 17:02 ACHC Acadia $51.35 / -3.16 (-5.80%) Sees FY21 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ACHC Acadia $51.35 / -3.16 (-5.80%) 02/09/21 Acadia to acquire Vallejo behavioral health services from Adventist Health 01/06/21 Medical Properties Trust to acquire GBP800M in behavioral hospitals 12/30/20 Acadia to sell U.K. operations to Waterland Private Equity for GBP 1,078M 12/09/20 Henry Ford Health System, Acadia partner to build behavioral health facility ACHC Acadia $51.35 / -3.16 (-5.80%) 12/31/20 Credit Suisse Acadia price target raised to $44 from $36 at Credit Suisse 12/30/20 Jefferies Jefferies ups Acadia price target to $60 on better than expected UK deal terms 12/18/20 Mizuho Acadia price target raised to $50 from $35 at Mizuho 11/17/20 UBS Acadia upgraded to Buy from Neutral at UBS ACHC Acadia $51.35 / -3.16 (-5.80%) 17:01 Today Acadia sees Q1 EPS 40c-45c, consensus 50c 17:00 Today Acadia reports Q4 EPS $1.13 incl discontinued ops, consensus 64c 10/29/20 Acadia reports Q3 adj. EPS 68c, consensus 54c 02/26/21 Acadia - ACHC
Earnings	Atreca reports Q4 EPS (63c), consensus (64c) » 17:02 02/25/21 02/25 17:02 02/25/21 17:02 BCEL Atreca $17.84 / -0.5 (-2.73%) "2020 was a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate Events BCEL Atreca $17.84 / -0.5 (-2.73%) 02/08/21 Jefferies Atreca initiated with a Buy at Jefferies 08/12/20 Stifel Volatility in Atreca shares creates 'interesting' opportunity, says Stifel 07/08/20 Piper Sandler Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler 07/01/20 Canaccord Atreca price target raised to $33 from $23 at Canaccord BCEL Atreca $17.84 / -0.5 (-2.73%) 11/12/20 Atreca reports Q3 EPS (66c), consensus (61c) 16 Jul 03/01/21 41st Annual Healthcare Virtual Conference

Events

Earnings calls, analyst events, roadshows and more

DELL
Today at 17:30

Dell Technologies - DELL Conference Calls
CVNA
Today at 17:30

Carvana - CVNA Conference Calls
CEA
Today at 21:00

China Transportation Industry Meetings
MAT
Tomorrow at 00:00

Mattel - MAT Conference Calls
MAT
Tomorrow at 00:00

Mattel - MAT Conference Calls
GSK ...
Tomorrow at 00:00

AAAAI Virtual Annual Meeting 2021 Conferences

Virtual Meeting
Tomorrow at 00:00

Cannabis Capital Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

22nd Annual Virtual Financial Services Forum Conferences

Virtual Forum
Tomorrow at 00:00

Emerging Technology Summit Conferences

Virtual Conference
Tomorrow at 00:00

Global ESG Virtual Conference 2021 Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	OUT X OUT Outfront Media Block Trade Managers: Morgan Stanley Priced at: $22.00 1.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BWAY X BWAY Brainsway Spot Secondary Managers: Oppenheimer Priced at: $8.50 4.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCL X CCL Carnival Spot Secondary Managers: Goldman Sachs Priced at: $25.10 40.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAVM X PAVM PAVmed Spot Secondary Managers: Cantor Fitzgerald Priced at: $4.60 9.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SHOP X SHOP Shopify Spot Secondary Managers: Citi, Credit Suisse & Goldman Sachs Priced at: $1,315 1.18M Shares
Tues	DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $42.70 11M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BCTX X BCTX BriaCell IPO Managers: ThinkEquity Priced at: $4.25 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BFRA X BFRA Biofrontera Secondary Managers: Benchmark, LAKE Priced at: $6.68 1.334M Shares FRPT X FRPT Freshpet Secondary Managers: BofA, Baird & Truist Priced at: $143.00 2.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CELC X CELC Celcuity Spot Secondary Managers: Craig-Hallum Priced at: $14.00 1.714M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SCR X SCR Score Media Secondary Managers: Morgan Stanley, Credit Suisse, Canaccord & Macquarie Priced at: $27.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TROX X TROX Tronox Secondary Managers: JPMorgan, BofA, Deutsche Bank, Morgan Stanley Priced at: $18.25 19.11M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ADMS X ADMS Adamas Pharmaceuticals Spot Secondary Managers: SVB Leerink, William Blair & JMP Securities Priced at: $4.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APEI X APEI American Public Education Spot Secondary Managers: Truist & William Blair Priced at: $25.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPRE X GPRE Green Plains Spot Secondary Managers: Jefferies & BofA Priced at: $23.00 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IFRX X IFRX InflaRx Spot Secondary Managers: Guggenheim & Raymond James Priced at: $5.00 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ITP X ITP IT Tech Packaging Spot Secondary Managers: Maxim Priced at: $.75 26.667M Shares RCEL X RCEL Avita Medical Spot Secondary Managers: Piper Sandler & Cowen Priced at: $21.50 2.795M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	APAM X APAM Artisan Partners Spot Secondary Managers: BofA $49.38 1.11M Shares
Thurs	GTES X GTES Gates Industrial Secondary Managers: Citi & Evercore ISI, Barclays, Credit Suisse, Goldman Sachs, Morgan Stanley, RBC Capital, UBS, Baird, Nomura, Wells Fargo, Guggenheim, KeyBanc $17.87 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Snap price target raised to $18 from $15 at Stifel

TODAY'S FREE FLY STORIES

Get Full Fly Access